University of Pennsylvania, Perelman Center — Philadelphia, Pennsylvania

University of Pennsylvania, Perelman Center is a clinical research site located in Philadelphia, Pennsylvania, United States 19104.

Crixeo Clinical Trials Trust Score: 91/100 (GOOD). This profile has not yet been claimed by the site owner.

University of Pennsylvania, Perelman Center has participated in 6 clinical trials with 1 currently active.

Therapeutic areas: Cutaneous T-cell Lymphoma (CTCL), Diffuse Cutaneous Systemic Sclerosis, Hepatopulmonary Syndrome.

Sponsors: Fox Chase Cancer Center, CSL Behring, University of Pennsylvania.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Philadelphia

Browse all research sites in Pennsylvania · View every site in Philadelphia

Sponsor Feasibility Report

Trust Score: 91/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of Pennsylvania, Perelman Center?

University of Pennsylvania, Perelman Center has a Crixeo Trust Score of 91/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of Pennsylvania, Perelman Center conducted?

University of Pennsylvania, Perelman Center has 6 clinical trials on record, with 1 currently active. Their work covers Cutaneous T-cell Lymphoma (CTCL), Diffuse Cutaneous Systemic Sclerosis, Hepatopulmonary Syndrome.

Is University of Pennsylvania, Perelman Center accredited by Crixeo Clinical Trials?

University of Pennsylvania, Perelman Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of Pennsylvania, Perelman Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.